(Q39433355)

11 September 2017

title

Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention (English)

1 reference

11 September 2017

1 reference

5

1 reference

11 September 2017

Tariq A Bhat

1

1 reference

11 September 2017

Dhanya Nambiar

series ordinal

2

1 reference

11 September 2017

Arttatrana Pal

series ordinal

3

1 reference

11 September 2017

Rajesh Agarwal

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

33

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

385-393

1 reference

Tumor angiogenesis: therapeutic implications

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Tumor angiogenesis: a potential target in cancer control by phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

VEGF: an update on biological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Tumor angiogenesis--a potential target in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Cancer chemoprevention through dietary antioxidants: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Molecular pathways for cancer angioprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Role of chemopreventive agents in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Targeting the cell cycle: a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Apoptosis and its clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

A first insight into the molecular mechanisms of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Pathways of apoptotic and non-apoptotic death in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Phosphorylation of Bcl2 and regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Tumour maintenance is mediated by eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Mechanism and its regulation of tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

Antiangiogenic mechanisms of diet-derived polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR282

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGR282

1 reference

11 September 2017

1 reference